Browse by Uncontrolled Keywords
Number of items: 5.
2009
Luna, KP;
Hernandez, IP;
Rueda, CM;
Zorro, MM;
Croft, SL;
Escobar, P;
(2009)
In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole.
Biomedica, 29 (3).
pp. 448-455.
ISSN 0120-4157
https://researchonline.lshtm.ac.uk/id/eprint/4496
Full text not available from this repository.
2006
Berman, J;
Bryceson, ADM;
Croft, S;
Engel, J;
Gutteridge, W;
Karbwang, J;
Sindermann, H;
Soto, J;
Sundar, S;
Urbina, JA;
(2006)
Miltefosine: issues to be addressed in the future.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 100 Su.
S41-4.
ISSN 0035-9203
DOI: https://doi.org/10.1016/j.trstmh.2006.02.009
Full text not available from this repository.
Croft, SL;
Seifert, K;
Yardley, V;
(2006)
Current scenario of drug development for leishmaniasis.
The Indian journal of medical research, 123 (3).
pp. 399-410.
ISSN 0971-5916
https://researchonline.lshtm.ac.uk/id/eprint/11722
Perez-Victoria, FJ;
Sanchez-Canete, MP;
Seifert, K;
Croft, SL;
Sundar, S;
Castanys, S;
Gamarro, F;
(2006)
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.
Drug resistance updates, 9 (1-2).
pp. 26-39.
ISSN 1368-7646
DOI: https://doi.org/10.1016/j.drup.2006.04.001
Full text not available from this repository.
2004
Bhattacharya, SK;
Jha, TK;
Sundar, S;
Thakur, CP;
Engel, J;
Sindermann, H;
Junge, K;
Karbwang, J;
Bryceson, ADM;
Berman, JD;
(2004)
Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.
Clinical infectious diseases, 38 (2).
pp. 217-221.
ISSN 1058-4838
DOI: https://doi.org/10.1086/380638
Full text not available from this repository.